Assessment of regulatory T-cell function in forthcoming clinical trials of cell therapy

References

• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10(7), 490–500 (2010).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27(1), 20–21 (2001).
   PubMed Web of Science ®Google Scholar
• Sagoo P, Lombardi G, Lechler RI. Regulatory T cells as therapeutic cells. Curr. Opin. Organ Transplant. 13(6), 645–653 (2008).
   PubMed Web of Science ®Google Scholar
• Hippen KL, Merkel SC, Schirm DK et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci. Transl. Med. 3(83), 83ra41 (2011).
   PubMed Web of Science ®Google Scholar
• Golovina TN, Mikheeva T, Brusko TM, Blazar BR, Bluestone JA, Riley JL. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS ONE 6(1), e15868 (2011).
   Google Scholar
• Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 90(12), 1321–1327 (2010).
   PubMed Web of Science ®Google Scholar
• Sagoo P, Ali N, Garg G, Nestle FO, Lechler RI, Lombardi G. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 3(83), 83ra42 (2011).
   PubMed Web of Science ®Google Scholar
• Nadig SN, Wieckiewicz J, Wu DC et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med. 16(7), 809–813 (2010).
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Bieniaszewska M, Juscinska J et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells. Clin. Immunol. 133(1), 22–26 (2009).
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Miller JS, Cao Q et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117(3), 1061–1070 (2011).
   PubMed Web of Science ®Google Scholar
• Di Ianni M, Falzetti F, Carotti A et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117(14), 3921–3928 (2011).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kuniyasu Y, Toda M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10(12), 1969–1980 (1998).
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188(2), 287–296 (1998).
   PubMed Web of Science ®Google Scholar
• Hasbold J, Gett AV, Rush JS et al. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol. 77(6), 516–522 (1999).
   PubMedGoogle Scholar
• Miyara M, Yoshioka Y, Kitoh A et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6), 899–911 (2009).
   PubMed Web of Science ®Google Scholar
• Canavan JB, Afzali B, Scottà C et al. A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood 119(8), e57–e66 (2012).
   PubMed Web of Science ®Google Scholar
• Ruitenberg JJ, Boyce C, Hingorani R, Putnam A, Ghanekar SA. Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 372(1–2), 95–106 (2011).
   PubMed Web of Science ®Google Scholar
• Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat. Med. 11(10), 1113–1117 (2005).
   PubMed Web of Science ®Google Scholar
• Ukena SN, Höpting M, Velaga S et al. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity. Exp. Hematol. 39(12), 1152–1160 (2011).
   PubMed Web of Science ®Google Scholar
• Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin. Exp. Immunol. 159(2), 120–130 (2010).
   PubMed Web of Science ®Google Scholar